The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCraven House Capital Regulatory News (CRV)

Share Price Information for Craven House Capital (CRV)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.20
Bid: 0.15
Ask: 0.25
Change: 0.00 (0.00%)
Spread: 0.10 (66.667%)
Open: 0.20
High: 0.20
Low: 0.20
Prev. Close: 0.20
CRV Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Year-end Update and Financial Calendar

3 Jul 2019 12:24

RNS Number : 3825E
Craven House Capital PLC
03 July 2019
 

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014.

 

Craven House Capital plc

 

("Craven House" or the "Company")

 

Year-end Update and Financial Calendar

 

Craven House Capital (AIM:CRV) is pleased to announce the following unaudited year-end investment update covering the year ending 31 May 2019.

 

Highlights

 

· Directors estimate that Net Asset Value ("NAV") per share has increased by 17% to $9.99 per share in the six-month period from November 2018 to May 2019.

 

· Changes in valuations reflect the previously announced repositioning of capital allocation and current investment focus in North America.

 

The table below sets out the latest estimate of the appropriate carrying value of the Company's investments as at 31 May 2019 in comparison to the values as of the latest published financial statements of the Company.

 

 

Investment

Estimated value at 31 May 19

(unaudited)

Value at 30 Nov 18 (unaudited)

 

 

 

Shares in Craven Industrial Holdings Plc

$27,605,161

$23,892,006

 

Comprising:

 

 

Shares in DLC Holdings Corp.

$8,757,041

$6,491,893

 Shares in Qeton Ltd

$650,206

$1,551,814

Shares in Craven House Angola LDA

$7,921,212

$8,903,150

Shares in Craven House Capital North America LLC

$7,907,782

$4,528,396

Shares in Kwikbuild Corporation Ltd

$2,368,919

$2,416,753

 

 

Portfolio update

 

The valuation of the Company's shareholding in Craven Industrial Holdings Plc ("CIH"), its principal wholly-owned investment holding company, has increased from $23.9m to $27.6m. This reflects the change in the respective value of subsidiary holdings as follows;

 

 

DLC Holdings Corp. (TSXV:DLC) - 68% owned by CRV

 

DLC is a Toronto Stock Exchange listed agricultural investment company with holdings in Brazil and South Africa. The valuation ascribed to CIH's shareholding in DLC in CRV's financial statements reflects the latest published share price of DLC's shares as of 31 May multiplied by the number of shares owned by CIH.

 

The valuation of DLC has increased due to an increase in the share price of DLC between Nov 18 and May 19.

 

 

Qeton Ltd ("Qeton") - 50% owned by CRV.

 

Qeton Ltd is a joint venture company focusing on the distribution of mobile phones, tablet computers and accessories into emerging markets.

 

The valuation of Qeton during the past six-month period has reduced from $1.55m to $0.650m reflecting a reduction in the earnings of Qeton during the period, with shares in Qeton valued at a multiple to net earnings based on the prior 12 months of trading. Whilst earnings have reduced, Qeton remains profitable and has a positive trading outlook.

 

 

Craven House Angola LDA ("CHA") - 100% owned by CRV.

 

Craven House Angola continued to provide local currency financing to Angolan subsidiaries of US and European companies in the consumer electronic and energy sectors. The carrying value of CHA's loan portfolio reduced from $8.9m to $7.9m during the six-month period to May 2019, reflecting the repayment of a portion of the outstanding loan facilities, in accordance with the terms of repayment. The proceeds of the repayments were passed to the parent company and utilized for general working capital purposes and for investment into Craven House's North American subsidiary.

 

Craven House Capital North America LLC ("CHNA") - 100% owned by CRV

 

The valuation of Craven's US investment holding company, CHNA, increased from $4.5m to $7.9m during the six months to May 2019. The majority of this increase reflects the successful sale of CHNA's wholly owned insurance business to LM Funding America Inc. ("LMFA") a NASDAQ listed entity as announced in January 2019. As of May 2019, CHNA owns c.25% of the common shares of LMFA and holds c.$3.6m in convertible notes in LMFA. CHNA also benefits from an equity portfolio valued at c.$3.5m, on a mark-to-market basis, as of May 2019.

 

 

 Kwikbuild Corporation Ltd. - 97% owned by CRV

 

There was little change in the valuation of Kwikbuild during the six-month period to the end of May 2019. The slight reduction in carrying value is the result of exchange rate movements and operating costs; the valuation of the underlying South African assets remained unchanged during this period. We continue with the process of liquidating our remaining holdings in South Africa.

 

 

Net Asset Value

 

As of the end of May 2019 the Directors estimate that the combined value of the other assets and liabilities of the Company represent a total liability of c.$2.6m. Of total liabilities of c.$3.6m, the majority (c.$2.4m) comprise intercompany loans or are due to related parties.

 

The approximate Net Asset Value of the Company therefore stood at c.$25.0m as of May 2019, equating to an NAV per share of $9.99 (vs. $8.57 as of November 2018). This estimate is prior to calculation of any performance fees due to the Investment Manager, which will be finalized following completion of the year-end audit.

 

Share buyback Update

 

The High Court has approved the reduction in share capital which is now subject to final formalities before being completed.

 

Financial Calendar

 

In order to provide shareholders with more regular information regarding the Company's investments, the Directors have decided to amend Craven House's reporting cycle to include, in addition to its interim and preliminary results, two further portfolio updates. These portfolio updates will occur shortly after the May year-end and November interim period in July and December respectively. This RNS forms the first of these new portfolio updates.

 

Going forward, the Company intends to follow the below financial timetable:

 

Anticipated date

Portfolio and NAV update

July

Preliminary financial results (for previous financial year)

Sept / Oct

Portfolio and NAV update

December

Interim Results

March

 

In addition to the above financial reporting calendar the Company will, in accordance with its obligations under the AIM Rules for Companies, make additional updates of matters which it considers appropriate. This may or may not include additional NAV updates.

 

 

 

~ Ends ~

 

 

For further information please contact:

 

Craven House Capital Plc

Mark Pajak

www.Cravenhousecapital.com

 

Tel: 0203 286 8130

 

 

SI Capital

Broker

Nick Emerson

www.sicapital.co.uk

Tel: 01483 413500

 

SPARK Advisory Partners Limited

Nominated Adviser

Matt Davis/Mark Brady

www.Sparkadvisorypartners.com

 

Tel: 0203 368 3550

 

 

 

About Craven House Capital:

 

The Company's Investing Policy is to invest in or acquire a portfolio of companies, partnerships, joint ventures, businesses or other assets globally in any geographic jurisdiction. The company will invest in both developed and developing markets providing long term patient capital and is often involved in special situations, restructuring, expansion and turn around investments in crisis and transitioning economies.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCUGUUPMUPBGGW
Date   Source Headline
18th Feb 20207:00 amRNSPlacing to raise $2m
13th Feb 20203:37 pmRNSTR-1: notification of major holdings
12th Feb 20202:05 pmRNSSecond Price Monitoring Extn
12th Feb 20202:00 pmRNSPrice Monitoring Extension
12th Feb 20207:00 amRNSPlacing to raise $1.9m
13th Jan 20207:00 amRNSCompletion of purchase of IIU, Inc. from LMFA
7th Jan 20202:03 pmRNSTR-1: Notification of major holdings
6th Jan 202010:54 amRNSResult of AGM
3rd Jan 20207:00 amRNSLoan Agreement with LMFA
2nd Jan 20207:00 amRNSPortfolio and NAV update
29th Nov 201910:57 amRNSTR-1: Notification of major holdings
28th Nov 20195:58 pmRNSAnnual Results for year ended 31 May 2019
25th Nov 20192:28 pmRNSTR-1: notification of major holdings
21st Nov 20191:08 pmRNSTR-1: notification of major holdings
20th Nov 20192:04 pmRNSTR-1: notification of major holdings
15th Nov 20192:37 pmRNSIssue of Equity
30th Oct 20193:56 pmRNSTR-1: notification of major holdings
21st Oct 20194:41 pmRNSSecond Price Monitoring Extn
21st Oct 20194:35 pmRNSPrice Monitoring Extension
17th Oct 20199:55 amRNSIssue of Equity
1st Oct 201911:15 amRNSTR-1: Form for notification of major holding
27th Sep 20192:18 pmRNSTR-1: Notification of major holdings
26th Sep 201911:52 amRNSPotential Acquisition
25th Sep 20194:41 pmRNSSecond Price Monitoring Extn
25th Sep 20194:35 pmRNSPrice Monitoring Extension
30th Aug 20195:18 pmRNSCraven House increases stake in LMFA
30th Aug 20197:00 amRNSIssue of Equity
22nd Jul 20194:56 pmRNSChange of Company Secretary, Issue of Equity
3rd Jul 201912:24 pmRNSYear-end Update and Financial Calendar
10th Jun 20195:17 pmRNSCraven House increases stake in LMFA
6th Jun 201912:22 pmRNSCraven House increases stake in LM Funding America
27th Feb 20195:15 pmRNSInterim Results
17th Jan 20191:54 pmRNSCompletion of sale of subsidiary
4th Jan 201911:22 amRNSResult of AGM and GM
20th Dec 20181:25 pmRNSPotential sale of subsidiary
12th Dec 20188:00 amRNSReduction in Capital Update
11th Dec 20184:34 pmRNSPosting of Annual Report and Notice of AGM
29th Nov 20181:36 pmRNSAnnual Results for year ended 31 May 2018
14th Nov 20187:00 amRNSAcquisition of shares in LM Funding America, Inc.
17th Oct 20188:13 amRNSBoard Change
24th Aug 20184:20 pmRNSResult of General Meeting
9th Aug 201810:02 amRNSNotice of General Meeting
28th Jun 20182:05 pmRNSSecond Price Monitoring Extn
28th Jun 20182:00 pmRNSPrice Monitoring Extension
11th Jun 20183:13 pmRNSSettlement of Legal Dispute
1st Jun 20182:49 pmRNSAcquisition of insurance broker in United States
24th Apr 20184:08 pmRNSDLC Holdings Update
20th Mar 20187:00 amRNSUpdate: DLC Holdings and Qeton
28th Feb 20187:00 amRNSInterim Results
7th Feb 20184:33 pmRNSFMCD Ltd partially repay Convertible Loan

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.